Health Care: Health Services

Biolase Inc (BIOL: NASDAQ)

$4.80 -0.08 | -1.62%

05/17/13 - 04:00 PM ET

Company Cash Flow

Cash Flow From Operating Activities
	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Net Income (Loss)	-3.06M	-4.49M	-12.02M	-2.96M
Operating Gains/Losses	256.00K	36.00K	55.00K	13.00K
Extraordinary Gains / Losses	0.00	0.00	0.00	0.00
(Increase) Decrease In Receivables	-3.22M	-5.64M	978.00K	-290.00K
(Increase) Decrease in Inventories	-160.00K	-4.72M	874.00K	3.46M
(Increase) Decrease In Other Current Assets	0.00	0.00	0.00	0.00
(Decrease) Increase In Payables	-347.00K	4.28M	-774.00K	-4.99M
(Decrease) Increase In Other Current Liabilities	417.00K	-5.71M	5.88M	0.00
(Increase) Decrease In Other Working Capital	1.07M	79.00K	-1.02M	-1.39M
Other Non-Cash Items	2.22M	2.52M	788.00K	2.31M
Net Cash From Continuing Operations	-1.66M	-13.32M	-3.81M	-2.57M
Net Cash From Discontinued Operations	0.00	0.00	0.00	0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities	-1.66M	-13.32M	-3.81M	-2.57M
Sale of Property, Plant & Equipment	124.00K	0.00	0.00	5.00K
Cash Used for Investing Activities
Sale of Short-Term Investments	0.00	0.00	0.00	0.00
Purchases of Property, Plant & Equipment	-822.00K	-428.00K	-237.00K	-449.00K
Acquisitions	0.00	0.00	0.00	0.00
Purchases of Short-Term Investments	0.00	0.00	0.00	0.00
Other Cash from Investing Activities	0.00	0.00	0.00	0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities	-698.00K	-428.00K	-237.00K	-444.00K
Issuance of Debt	16.60M	0.00	3.00M	4.29M
Cash Used for Financing Activities
Issuance of Capital Stock	461.00K	18.47M	199.00K	173.00K
Repayment of Long-Term Debt	-14.96M	-2.70M	0.00	-9.70M
Repurchase of Capital Stock	-235.00K	-268.00K	0.00	0.00
Payment of Cash Dividends	0.00	0.00	0.00	0.00
Other Financing Charges, Net	-304.00K	-112.00K	-385.00K	0.00
Net Cash From Financing Activities	1.56M	15.39M	2.81M	-5.23M
Effect of Exchange Rate Changes	39.00K	-26.00K	-46.00K	-14.00K
Net Change in Cash & Cash Equivalents	-764.00K	1.61M	-1.28M	-8.26M